Nurix

Last updated: April 19, 2024

Co-Founder John Kuriyan
Co-Founder John Kuriyan
Country: USA | Funding: $370.9M (+)

Website: https://www.nurixtx.com/

Nurix develops small molecule inhibitors for the treatment of proliferative and degenerative diseases.